Therefore, through functional interactions with immune cells, TRAIL can directly inhibit tumor cell growth by inducing cancer cell apoptosis and promoting the recruitment of immune cells (monocytes/macrophages) through chemokine secretion to kill cancer cells [146]. Here, TNFSF10 is linked to neoplasm.